Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21Cip1 and p27Kip1

BMB Reports

Volumn 46, Issue 1, 2013, Pages 25-30

  Jee, Hyang ^a   Lee, Su Hyung ^a   Park, Jun Won ^a   Lee, Bo Ram ^a   Nam, Ki Taek ^b   Kim, Dae Yong ^a  

^a Seoul National University   (South Korea)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AGS cells; Cell cycle distribution; Cell proliferation; Connexin32; Gastric cancer

Indexed keywords

CONNEXIN 32; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GAP JUNCTION PROTEIN; KI 67 ANTIGEN;

ARTICLE; CELL PROLIFERATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CONNEXINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; STOMACH NEOPLASMS; TRANSFECTION; UP-REGULATION;

EID: 84874683070     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.1.078     Document Type: Article

References (33)

1. Hohenberger, P. and Gretschel, S. (2003) Gastric cancer. Lancet 362, 305-315.
2. Jung, K. W., Park, S., Kong, H. J., Won, Y. J., Lee, J. Y., Park, E. C. and Lee, J. S. (2011) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res. Treat. 43, 1-11.
3. Correa, P. (1992) Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52, 6735-6740.
4. Correa, P. and Houghton, J. (2007) Carcinogenesis of Helicobacter pylori. Gastroenterology 133, 659-672.
5. Kwon, H. J., Won, Y. S., Nam, K. T., Yoon, Y. D., Jee, H., Yoon, W. K., Nam, K. H., Kang, J. S., Han, S. U., Choi, I. P., Kim, D. Y. and Kim, H. C. (2012) Vitamin D upregulated protein 1 deficiency promotes N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric carcinogenesis in mice. Gut 61, 53-63.
6. Crabtree, J. E., Court, M., Aboshkiwa, M. A., Jeremy, A. H., Dixon, M. F. and Robinson, P. A. (2004) Gastric mucosal cytokine and epithelial cell responses to Helicobacter pylori infection in Mongolian gerbils. J. Pathol. 202, 197-207.
7. Vinken, M., Henkens, T., De Rop, E., Fraczek, J., Vanhaecke, T. and Rogiers, V. (2008) Biology and pathobiology of gap junctional channels in hepatocytes. Hepatology 47, 1077-1088.
8. Laird, D. W. (2006) Life cycle of connexins in health and disease. Biochem. J. 394, 527-543.
9. Mroue, R. M., El-Sabban, M. E. and Talhouk, R. S. (2011) Connexins and the gap in context. Integr. Biol. (Camb) 3, 255-266.
10. Willecke, K., Eiberger, J., Degen, J., Eckardt, D., Romualdi, A., Guldenagel, M., Deutsch, U. and Sohl, G. (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem. 383, 725-737.
11. Radebold, K., Horakova, E., Gloeckner, J., Ortega, G., Spray, D. C., Vieweger, H., Siebert, K., Manuelidis, L. and Geibel, J. P. (2001) Gap junctional channels regulate acid secretion in the mammalian gastric gland. J. Membr. Biol. 183, 147-153.
12. Uchida, Y., Matsuda, K., Sasahara, K., Kawabata, H. and Nishioka, M. (1995) Immunohistochemistry of gap junctions in normal and diseased gastric mucosa of humans. Gastroenterology 109, 1492-1496.
13. Kanczuga-Koda, L., Sulkowski, S., Koda, M. and Sulkowska, M. (2005) Alterations in connexin26 expression during colorectal carcinogenesis. Oncology 68, 217-222.
14. Torres, L. N., Matera, J. M., Vasconcellos, C. H., Avanzo, J. L., Hernandez-Blazquez, F. J. and Dagli, M. L. (2005) Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands. Vet. Pathol. 42, 633-641.
15. Omori, Y., Li, Q., Nishikawa, Y., Yoshioka, T., Yoshida, M., Nishimura, T. and Enomoto, K. (2007) Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression. J. Membr. Biol. 218, 73-77.
16. Jee, H., Nam, K. T., Kwon, H. J., Han, S. U. and Kim, D. Y. (2011) Altered expression and localization of connexin32 in human and murine gastric carcinogenesis. Dig. Dis. Sci. 56, 1323-1332.
17. Avanzo, J. L., Mesnil, M., Hernandez-Blazquez, F. J., da Silva, T. C., Fukumasu, H., Mori, C. M., Yamasaki, H. and Dagli, M. L. (2006) Altered expression of connexins in urethane-induced mouse lung adenomas. Life Sci. 79, 2202-2208.
18. Udaka, N., Miyagi, Y. and Ito, T. (2007) Connexin expression in mouse lung tumor. Cancer Lett. 246, 224-229.
19. Sanches, D. S., Pires, C. G., Fukumasu, H., Cogliati, B., Matsuzaki, P., Chaible, L. M., Torres, L. N., Ferrigno, C. R. and Dagli, M. L. (2009) Expression of connexins in normal and neoplastic canine bone tissue. Vet. Pathol. 46, 846-859.
20. Edwards, G. O., Jondhale, S., Chen, T. and Chipman, J. K. (2008) A quantitative inverse relationship between connexin32 expression and cell proliferation in a rat hepatoma cell line. Toxicology 253, 46-52.
21. Xu, H. T., Li, Q. C., Zhang, Y. X., Zhao, Y., Liu, Y., Yang, Z. Q. and Wang, E. H. (2008) Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia. Histochem. Cytobiol. 46, 315-321.
22. Hunter, T. and Pines, J. (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
23. Ford, H. L., Sclafani, R. A. and DeGregori, J. (2004) Cell cycle regulatory cascades; in Cell cycle and growth control: Biomolecular regulation and cancer (Stein, G. S. and Pardee, A. B., eds.), pp. 95-128, Wiley-Liss, Hoboken, USA.
24. Avanzo, J. L., Mesnil, M., Hernandez-Blazquez, F. J., Mackowiak, II, Mori, C. M., da Silva, T. C., Oloris, S. C., Garate, A. P., Massironi, S. M., Yamasaki, H. and Dagli, M. L. (2004) Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. Carcinogenesis 25, 1973-1982.
25. Temme, A., Buchmann, A., Gabriel, H. D., Nelles, E., Schwarz, M. and Willecke, K. (1997) High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr. Biol. 7, 713-716.
26. Huang, R. P., Fan, Y., Hossain, M. Z., Peng, A., Zeng, Z. L. and Boynton, A. L. (1998) Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res. 58, 5089-5096.
27. Krutovskikh, V. A., Troyanovsky, S. M., Piccoli, C., Tsuda, H., Asamoto, M. and Yamasaki, H. (2000) Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 19, 505-513.
28. Olbina, G. and Eckhart, W. (2003) Mutations in the second extracellular region of connexin 43 prevent localization to the plasma membrane, but do not affect its ability to suppress cell growth. Mol. Cancer Res. 1, 690-700.
29. Zhang, Y. W., Morita, I., Ikeda, M., Ma, K. W. and Murota, S. (2001) Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene 20, 4138-4149.
30. Koffler, L., Roshong, S., Kyu Park, I., Cesen-Cummings, K., Thompson, D. C., Dwyer-Nield, L. D., Rice, P., Mamay, C., Malkinson, A. M. and Ruch, R. J. (2000) Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1) after forced connexin expression in lung and liver carcinoma cells. J. Cell. Biochem. 79, 347-354.
31. Sanchez-Alvarez, R., Paino, T., Herrero-Gonzalez, S., Medina, J. M. and Tabernero, A. (2006) Tolbutamide reduces glioma cell proliferation by increasing connexin43, which promotes the up-regulation of p21 and p27 and subsequent changes in retinoblastoma phosphorylation. Glia 54, 125-134.
32. Giepmans, B. N. (2004) Gap junctions and connexin-interacting proteins. Cardiovasc. Res. 62, 233-245.
33. Kumar, N. M. and Gilula, N. B. (1986) Cloning and characterization of human and rat liver cDNAs coding for a gap junction protein. J. Cell. Biol. 103, 767-776.